Allopurinol - AdvancellAlternative Names: ATH-008; ATH-008 cream
Latest Information Update: 12 Aug 2015
At a glance
- Originator Nobera Pharma
- Developer Advancell
- Class Antigouts; Purines; Skin disorder therapies
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Erythrodysaesthesia; Unspecified